ACP-105 – Beligas Pharma USA
ACP-105 by Beligas Pharma USA is a selective androgen receptor modulator (SARM) research compound manufactured under quality-controlled production standards. The product is intended for laboratory research purposes only and is supplied for scientific investigation into selective androgen receptor activity.
ACP-105 is an investigational compound that has been studied in preclinical research for its selective interaction with androgen receptors. Researchers have explored its potential effects on muscle, bone, and other androgen-responsive tissues. However, ACP-105 is not approved by major regulatory authorities for the treatment, prevention, or diagnosis of any medical condition.
Product Highlights
- Brand: Beligas Pharma USA
- Product Name: ACP-105
- Compound: ACP-105
- Product Type: Selective Androgen Receptor Modulator (SARM)
- Manufactured under quality-controlled production standards
- Intended for laboratory research purposes only
Product Information
ACP-105 is an investigational SARM that has been evaluated in laboratory and preclinical studies for its selective binding to androgen receptors. Scientific research has focused on its pharmacological characteristics and tissue-selective activity, but research remains ongoing.
This product is supplied exclusively for research applications. For complete information regarding formulation, packaging, batch details, analytical testing, and storage recommendations, consult the manufacturer’s official documentation.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | ACP-105 |
| Brand | Beligas Pharma USA |
| Compound | ACP-105 |
| Product Type | Selective Androgen Receptor Modulator (SARM) |
| Intended Use | Research Use Only |
| Manufacturer | Beligas Pharma USA |
Storage Instructions
- Store according to the manufacturer’s recommended conditions.
- Protect from excessive heat, moisture, and direct sunlight.
- Keep the container tightly sealed when not in use.
- Handle using appropriate laboratory procedures.
Important Information
ACP-105 is an investigational research compound. It is not approved for human or veterinary therapeutic use, and its safety and effectiveness have not been established by major regulatory authorities. This product is intended exclusively for laboratory research and should be handled by qualified professionals in accordance with applicable regulations.



